Insights On Clinical Technologies

  1. Experts Discuss AI's Future In Pharma 5/1/2024

    At the J.P. Morgan Health Conference, experts explored the transformative potential of artificial intelligence (AI) in drug development and deliberated on the essential requirements for ensuring positive outcomes in this evolving field.

  2. Waiver Of Consent vs Waiver Of Written Consent 11/21/2024

    Learn the distinctions between a Waiver of Consent and a Waiver of Written Consent in clinical trials, and the importance of informed consent, particularly in the context of virtual trials.

  3. Parkinson's Disease: Leveraging Wearable DHTs 10/22/2024

    Wearable DHTs offer a solution to the challenges of measuring Parkinson's disease in clinical trials. Discover how these technologies can improve outcome measures and accelerate drug development.

  4. Signant StudyIQ Trial Management Suite Overview 7/16/2024

    See how our dynamic and rich reporting solutions facilitate high-quality clinical data and support efficient trial management. All reports, dashboards, and analytics come standard with our eCOA solutions.

  5. A Patient-Centric Approach To eConsent 8/23/2023

    Discover how electronic consent solutions centered around patients' needs can effectively alleviate challenges for both patients and research sites.

  6. Exploring Value-Based Contracting In Rare Diseases 4/14/2025

    How are payers using value-based contracts for costly rare disease therapies? Exploratory research sheds light on negotiation frequency, preferred contract types, and internal data management trends.

  7. Build Vs. Buy Vs. Partner In Life Sciences: Making The Right Call 3/21/2025

    Discover when life sciences organizations should develop technology in-house, buy off-the-shelf solutions, or form strategic partnerships, exploring the costs and risks that come with each approach.

  8. Revolutionizing CRO Financial Management With Better Technology 6/19/2024

    For contract research organizations (CROs), the reliance on Excel is giving way to specialized technology, marking a pivotal shift in financial management strategies.

  9. Treatment Benefits Of Wearable DHTs For Patients With Cancer Cachexia 11/20/2024

    Wearable digital health technologies (DHTs) played a crucial role in assessing patient-centric outcomes during pfizer's study into the benefits of using ponsegromab for treating cancer cachexia.

  10. RWD For Early Clinical Development Planning And Strategy 9/19/2023

    Delve into this use case where Citeline’s Real-World Data was used to inform clinical development strategy and differentiate target product profiles through patient journey mapping.